Please wait
Healthcare · Medical Devices · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$32.4B
19.0%
16.53
Current price
$71.41
-0.4% todayUpdated 47 min ago
Open
$72.82
Previous close
$71.72
Day range
$70.29 – $73.01
Volume
N/A
16.5x P/E
Awaiting filing
19.0% yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for GEHC, with its range and direction at a glance.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Investors usually follow GEHC for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 75/100 while there is no strong bear warning from the current data. Whisone has high conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$560M
TTM (2026-06-30)
ROE
19.4%
Return on equity
ROA
5.1%
Return on assets
Debt / equity
0.96
Lower is usually safer.
P/B ratio
2.95
Useful for book value support.
Dividend yield
19.0%
Current income signal.
85/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
$77.11
Analyst view
Buy
Analyst target
$82.50
Forecast refresh
Updated 14h ago
Quality score
74
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
$0.04
2025-01-14
Payment: TBA | Qualification: 2025-01-14 | Yield at declaration: N/A
$0.03
2024-10-18
Payment: TBA | Qualification: 2024-10-18 | Yield at declaration: N/A
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+5.0% across the latest saved price window.
Volatility
Moderate
Beta is 0.82. Price sensitivity is broadly around the market range.
52-week position
41% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
N/A
Comparable volume data is not available.
high_energy_costs
GEHC may also move because the HEALTHCARE sector may move with high_energy_costs. Confidence 63%.
PMG-MAN stated the pharmaceutical sector spends a large share of revenue on energy, reducing competitiveness industry-wide.
policy_stability_and_support
GEHC may also move because the HEALTHCARE sector may benefit from policy_stability_and_support. Confidence 60%.
The sector would benefit from extended Presidential Executive Order, dedicated energy tariffs, and policies encouraging local API production to attract investment and boost local manufacturing.
GEHC
GE HealthCare Technologies Inc.
Price: $71.41
P/E: 16.526497
Yield: 19.0%
ABBV
AbbVie Inc.
Price: $257.80
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.49
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $159.32
P/E: 27.310226
Yield: 0.0%
Industry
Medical Devices
Employees
54000
Exchange
NMS
Ticker
GEHC
